Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Working Capital Changes (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Other Working Capital Changes for 7 consecutive years, with $439855.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 3743.9% to $439855.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $401795.0, a 86.55% decrease, with the full-year FY2025 number at -$50131.0, down 101.02% from a year prior.
  • Other Working Capital Changes was $439855.0 for Q4 2025 at Outlook Therapeutics, up from -$13007.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $439855.0 in Q4 2025 to a low of -$13007.0 in Q3 2025.